Cargando…
Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines
This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. A rational plan to manage the neck is necessary for all head and neck primaries. With the emergence of new level 1 evidence across several domains of neck metastases...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873907/ https://www.ncbi.nlm.nih.gov/pubmed/27841133 http://dx.doi.org/10.1017/S002221511600058X |
_version_ | 1782432963875569664 |
---|---|
author | Paleri, V Urbano, T G Mehanna, H Repanos, C Lancaster, J Roques, T Patel, M Sen, M |
author_facet | Paleri, V Urbano, T G Mehanna, H Repanos, C Lancaster, J Roques, T Patel, M Sen, M |
author_sort | Paleri, V |
collection | PubMed |
description | This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. A rational plan to manage the neck is necessary for all head and neck primaries. With the emergence of new level 1 evidence across several domains of neck metastases, this guideline will identify the evidence-based recommendations for management. RECOMMENDATIONS: • Computed tomographic or magnetic resonance imaging is mandatory for staging neck disease, with choice of modality dependant on imaging modality used for the primary site, local availability and expertise. (R) • Patients with a clinically N0 neck, with more than 15–20 per cent risk of occult nodal metastases, should be offered prophylactic treatment of the neck. (R) • The treatment choice of for the N0 and N+ neck should be guided by the treatment to the primary site. (G) • If observation is planned for the N0 neck, this should be supplemented by regular ultrasonograms to ensure early detection. (R) • All patients with T1 and T2 oral cavity cancer and N0 neck should receive prophylactic neck treatment. (R) • Selective neck dissection (SND) is as effective as modified radical neck dissection for controlling regional disease in N0 necks for all primary sites. (R) • SND alone is adequate treatment for pN1 neck disease without adverse histological features. (R) • Post-operative radiation for adverse histologic features following SND confers control rates comparable with more extensive procedures. (R) • Adjuvant radiation following surgery for patients with adverse histological features improves regional control rates. (R) • Post-operative chemoradiation improves regional control in patients with extracapsular spread and/or microscopically involved surgical margins. (R) • Following chemoradiation therapy, complete responders who do not show evidence of active disease on co-registered positron emission tomography–computed tomography (PET–CT) scans performed at 10–12 weeks, do not need salvage neck dissection. (R) • Salvage surgery should be considered for those with incomplete or equivocal response of nodal disease on PET–CT. (R) |
format | Online Article Text |
id | pubmed-4873907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48739072016-05-27 Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines Paleri, V Urbano, T G Mehanna, H Repanos, C Lancaster, J Roques, T Patel, M Sen, M J Laryngol Otol Guidelines This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. A rational plan to manage the neck is necessary for all head and neck primaries. With the emergence of new level 1 evidence across several domains of neck metastases, this guideline will identify the evidence-based recommendations for management. RECOMMENDATIONS: • Computed tomographic or magnetic resonance imaging is mandatory for staging neck disease, with choice of modality dependant on imaging modality used for the primary site, local availability and expertise. (R) • Patients with a clinically N0 neck, with more than 15–20 per cent risk of occult nodal metastases, should be offered prophylactic treatment of the neck. (R) • The treatment choice of for the N0 and N+ neck should be guided by the treatment to the primary site. (G) • If observation is planned for the N0 neck, this should be supplemented by regular ultrasonograms to ensure early detection. (R) • All patients with T1 and T2 oral cavity cancer and N0 neck should receive prophylactic neck treatment. (R) • Selective neck dissection (SND) is as effective as modified radical neck dissection for controlling regional disease in N0 necks for all primary sites. (R) • SND alone is adequate treatment for pN1 neck disease without adverse histological features. (R) • Post-operative radiation for adverse histologic features following SND confers control rates comparable with more extensive procedures. (R) • Adjuvant radiation following surgery for patients with adverse histological features improves regional control rates. (R) • Post-operative chemoradiation improves regional control in patients with extracapsular spread and/or microscopically involved surgical margins. (R) • Following chemoradiation therapy, complete responders who do not show evidence of active disease on co-registered positron emission tomography–computed tomography (PET–CT) scans performed at 10–12 weeks, do not need salvage neck dissection. (R) • Salvage surgery should be considered for those with incomplete or equivocal response of nodal disease on PET–CT. (R) Cambridge University Press 2016-05 /pmc/articles/PMC4873907/ /pubmed/27841133 http://dx.doi.org/10.1017/S002221511600058X Text en © JLO (1984) Limited 2016 http://creativecommons.org/licenses/by/4.0/ This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Guidelines Paleri, V Urbano, T G Mehanna, H Repanos, C Lancaster, J Roques, T Patel, M Sen, M Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines |
title | Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines |
title_full | Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines |
title_fullStr | Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines |
title_full_unstemmed | Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines |
title_short | Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines |
title_sort | management of neck metastases in head and neck cancer: united kingdom national multidisciplinary guidelines |
topic | Guidelines |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873907/ https://www.ncbi.nlm.nih.gov/pubmed/27841133 http://dx.doi.org/10.1017/S002221511600058X |
work_keys_str_mv | AT paleriv managementofneckmetastasesinheadandneckcancerunitedkingdomnationalmultidisciplinaryguidelines AT urbanotg managementofneckmetastasesinheadandneckcancerunitedkingdomnationalmultidisciplinaryguidelines AT mehannah managementofneckmetastasesinheadandneckcancerunitedkingdomnationalmultidisciplinaryguidelines AT repanosc managementofneckmetastasesinheadandneckcancerunitedkingdomnationalmultidisciplinaryguidelines AT lancasterj managementofneckmetastasesinheadandneckcancerunitedkingdomnationalmultidisciplinaryguidelines AT roquest managementofneckmetastasesinheadandneckcancerunitedkingdomnationalmultidisciplinaryguidelines AT patelm managementofneckmetastasesinheadandneckcancerunitedkingdomnationalmultidisciplinaryguidelines AT senm managementofneckmetastasesinheadandneckcancerunitedkingdomnationalmultidisciplinaryguidelines |